Intelligent Bio Solutions Future Growth
Future criteria checks 5/6
Intelligent Bio Solutions is forecast to grow earnings and revenue by 78.1% and 91.6% per annum respectively while EPS is expected to grow by 100.8% per annum.
Key information
78.1%
Earnings growth rate
100.8%
EPS growth rate
Medical Equipment earnings growth | 16.6% |
Revenue growth rate | 91.6% |
Future return on equity | n/a |
Analyst coverage | Low |
Last updated | 18 Jun 2024 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
6/30/2026 | 26 | 2 | N/A | N/A | 1 |
6/30/2025 | 12 | -6 | N/A | -1 | 1 |
6/30/2024 | 4 | -9 | N/A | -4 | 1 |
3/31/2024 | 3 | -10 | -7 | -7 | N/A |
12/31/2023 | 2 | -13 | -7 | -7 | N/A |
9/30/2023 | 2 | -12 | -7 | -7 | N/A |
6/30/2023 | 1 | -11 | -8 | -7 | N/A |
3/31/2023 | 1 | -10 | -9 | -9 | N/A |
12/31/2022 | 0 | -5 | -7 | -6 | N/A |
9/30/2022 | N/A | -8 | -6 | -5 | N/A |
6/30/2022 | N/A | -8 | -4 | -3 | N/A |
3/31/2022 | 2 | -7 | -3 | -3 | N/A |
12/31/2021 | 2 | -9 | -9 | -9 | N/A |
9/30/2021 | 2 | -7 | -9 | -9 | N/A |
6/30/2021 | 2 | -7 | -11 | -11 | N/A |
3/31/2021 | 0 | -7 | -9 | -9 | N/A |
12/31/2020 | 0 | -4 | -3 | -3 | N/A |
9/30/2020 | 0 | -3 | -3 | -3 | N/A |
6/30/2020 | 0 | -3 | 0 | 0 | N/A |
3/31/2020 | 0 | -6 | -5 | -5 | N/A |
12/31/2019 | 0 | -7 | -6 | -6 | N/A |
9/30/2019 | 0 | -6 | -5 | -5 | N/A |
6/30/2019 | N/A | -7 | -6 | -6 | N/A |
3/31/2019 | 0 | -6 | -4 | -4 | N/A |
12/31/2018 | N/A | -5 | -4 | -4 | N/A |
9/30/2018 | N/A | -6 | -5 | -5 | N/A |
6/30/2018 | N/A | -5 | -5 | -5 | N/A |
3/31/2018 | 0 | -3 | -3 | -3 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: INBS is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2.4%).
Earnings vs Market: INBS is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: INBS is expected to become profitable in the next 3 years.
Revenue vs Market: INBS's revenue (91.6% per year) is forecast to grow faster than the US market (8.7% per year).
High Growth Revenue: INBS's revenue (91.6% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if INBS's Return on Equity is forecast to be high in 3 years time